Pacira Historical Financial Ratios
PCRX Stock | USD 17.38 0.35 2.06% |
Pacira BioSciences, is promptly reporting on over 108 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 19.77, Free Cash Flow Yield of 0.0939, Invested Capital of 0.0 or Operating Cash Flow Per Share of 3.51 will help investors to properly organize and evaluate Pacira BioSciences, financial condition quickly.
Pacira |
About Pacira Financial Ratios Analysis
Pacira BioSciences,Financial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pacira BioSciences, investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pacira financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pacira BioSciences, history.
Pacira BioSciences, Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Pacira BioSciences, stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pacira BioSciences, sales, a figure that is much harder to manipulate than other Pacira BioSciences, multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Pacira BioSciences, dividend as a percentage of Pacira BioSciences, stock price. Pacira BioSciences, dividend yield is a measure of Pacira BioSciences, stock productivity, which can be interpreted as interest rate earned on an Pacira BioSciences, investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Revenue Per Share
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.Quick Ratio
A measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities.Most ratios from Pacira BioSciences,'s fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pacira BioSciences, current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacira BioSciences,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.At this time, Pacira BioSciences,'s Interest Coverage is fairly stable compared to the past year. Payout Ratio is likely to rise to 0.06 in 2024, whereas Price To Sales Ratio is likely to drop 2.19 in 2024.
2021 | 2023 | 2024 (projected) | Dividend Yield | 0.001004 | 0.001154 | 0.001442 | Price To Sales Ratio | 4.92 | 2.31 | 2.19 |
Pacira BioSciences, fundamentals Correlations
Click cells to compare fundamentals
Pacira BioSciences, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pacira BioSciences, fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 4.47 | 6.07 | 4.92 | 2.64 | 2.31 | 2.19 | |
Ptb Ratio | 5.3 | 4.12 | 3.65 | 2.27 | 1.79 | 1.7 | |
Days Sales Outstanding | 41.21 | 46.01 | 64.92 | 53.86 | 57.08 | 37.42 | |
Book Value Per Share | 8.55 | 14.52 | 16.5 | 17.03 | 18.83 | 19.77 | |
Free Cash Flow Yield | 0.0321 | 0.0154 | 0.03 | 0.0655 | 0.0894 | 0.0939 | |
Operating Cash Flow Per Share | 1.7 | 1.81 | 2.84 | 3.19 | 3.35 | 3.51 | |
Stock Based Compensation To Revenue | 0.0941 | 0.0799 | 0.0949 | 0.078 | 0.0721 | 0.071 | |
Capex To Depreciation | 0.52 | 1.9 | 1.61 | 0.33 | 0.2 | 0.19 | |
Pb Ratio | 5.3 | 4.12 | 3.65 | 2.27 | 1.79 | 1.7 | |
Free Cash Flow Per Share | 1.45 | 0.92 | 1.8 | 2.53 | 3.02 | 3.17 | |
Roic | 0.0587 | 0.31 | 0.0548 | 0.0487 | 0.0428 | 0.045 | |
Inventory Turnover | 1.83 | 1.81 | 1.42 | 2.07 | 1.77 | 1.68 | |
Net Income Per Share | (0.0115) | (0.27) | 3.41 | 0.95 | 0.35 | 0.91 | |
Days Of Inventory On Hand | 199.4 | 201.12 | 256.47 | 175.94 | 206.25 | 118.98 | |
Payables Turnover | 8.34 | 11.25 | 13.3 | 13.09 | 11.76 | 7.23 | |
Capex To Revenue | 0.0241 | 0.0898 | 0.0847 | 0.0451 | 0.0225 | 0.0213 | |
Cash Per Share | 7.03 | 12.23 | 14.83 | 6.34 | 6.03 | 8.93 | |
Pocfratio | 26.67 | 33.15 | 21.18 | 12.1 | 10.08 | 9.58 | |
Interest Coverage | 1.61 | 1.81 | 4.13 | 1.5 | 4.32 | 4.53 | |
Capex To Operating Cash Flow | 0.14 | 0.49 | 0.36 | 0.21 | 0.098 | 0.0931 | |
Pfcf Ratio | 31.15 | 65.09 | 33.35 | 15.26 | 11.18 | 11.74 | |
Days Payables Outstanding | 43.78 | 32.45 | 27.44 | 27.87 | 31.03 | 29.48 | |
Income Quality | (6.4) | 0.53 | 2.99 | 9.13 | 3.69 | 3.87 | |
Roe | (0.031) | 0.23 | 0.0575 | 0.0205 | 0.0482 | 0.0506 | |
Ev To Operating Cash Flow | 30.55 | 38.87 | 25.51 | 16.64 | 12.88 | 23.5 | |
Pe Ratio | (170.71) | 17.55 | 63.44 | 110.48 | 37.17 | 39.03 | |
Return On Tangible Assets | (0.0176) | 0.13 | 0.0321 | 0.0163 | 0.0452 | 0.0475 | |
Ev To Free Cash Flow | 35.69 | 76.33 | 40.16 | 20.98 | 14.28 | 15.0 | |
Earnings Yield | (0.005858) | 0.057 | 0.0158 | 0.009052 | 0.0269 | 0.0282 | |
Intangibles To Total Assets | 0.25 | 0.15 | 0.37 | 0.42 | 0.41 | 0.43 | |
Net Debt To E B I T D A | 4.95 | 6.18 | 4.59 | 4.55 | 2.66 | 2.79 | |
Current Ratio | 3.79 | 2.57 | 1.66 | 3.37 | 5.24 | 5.5 | |
Tangible Book Value Per Share | 3.64 | 9.93 | (0.88) | 1.56 | 4.84 | 5.08 | |
Receivables Turnover | 8.86 | 7.93 | 5.62 | 6.78 | 6.39 | 9.03 | |
Graham Number | 7.14 | 33.38 | 18.77 | 11.57 | 19.61 | 37.65 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pacira Stock Analysis
When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.